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INTRODUCTION
Involvement of the inferior vena cava (IVC) has been re-
ported in up to 35% of patients with renal cell carcinoma
(RCC) (1-6). Although complete removal of the extension
of the tumor thrombus into the IVC does not affect patient
prognosis (7, 8), non-removal has been associated with poor
survival rates (7). The most effective therapeutic option in
patients with RCC and IVC tumor thrombus is aggressive
surgical resection, including radical nephrectomy with IVC
thrombectomy, even in patients with distant metastases (8-
11). Five-year survival rates following surgery have been re-
ported to range from 32% to 64% (2, 6, 7, 9).
Even with improvements in preoperative diagnostic modal-
ities, anesthesiology, and perioperative care, there is still con-
siderable morbidity and mortality in this type of surgery,
ranging from 2.7% to 40% (3, 8, 12), arising primarily from
massive pulmonary embolism and hemorrhage (7, 13). These
complications are closely related to the cephalic extension of
the IVC tumor thrombus, suggesting that radical surgery
should be reserved for patients with tumor thrombi extend-
ing beyond the level of the diaphragm (12). We have design-
ed a safe and successful surgical strategy through a review of
our surgical experience. 
MATERIALS AND METHODS 
From January 1997 to December 2006, 35 patients at the
Asan Medical Center, Seoul, Korea, underwent IVC tumor
thrombectomy with radical nephrectomy, performed by uro-
logical and vascular surgeons. Preoperative assessment of dis-
tant metastases and extents of thrombus was determined main-
ly by computed tomography (CT) of the thorax, abdomen,
and pelvis. Nineteen patients underwent magnetic resonance
image (MRI). After discharge, patients were followed up every
3 months and CT scans were performed every 6 months.
Tumors were classified according to the TNM classifica-
tion of the UICC International Union against Cancer (IUAC)
(14). Extent of the thrombus was graded at level I or renal
(i.e., extending ≤2 cm above the ostium of the renal vein
into the IVC); level II or infrahepatic (i.e., extending >2 cm
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Surgical Treatment of Inferior Vena Cava Tumor Thrombus in Patients
with Renal Cell Carcinoma
Radical nephrectomy with inferior vena cava (IVC) thrombectomy remains the most
effective therapeutic option in patients with renal cell carcinoma and IVC tumor throm-
bus. Cephalic extension of the thrombus is closely related to perioperative morbidi-
ty. We purposed to design a safe and successful surgical strategy through a review
of our surgical experience and treatment results in 35 patients (male:female=28:7,
mean age=56 yr [32-77]) who underwent IVC thrombectomy with radical nephrec-
tomy between January 1997 and December 2006. The limit of tumor extension was
level I in 10 patients (28.6%), level II in 17 (48.6%), and level III and IV in 4 patients
each (11.4%). Liver mobilization with hepatic vascular exclusion was performed in
12 patients and cardiopulmonary bypass in 7. Thirty-two primary closures, 2 patch
closures, and 1 graft interposition were performed. One patient underwent simulta-
neous pulmonary embolectomy because of an operative pulmonary embolism. There
was no operative mortality, and the overall survival at 5-yr was 50.8%. Complete
thrombus removal without tumor fragmentation under long venotomy on fully ex-
posed involved IVC is recommended for successful result in a bloodless operative
field. The applicability of liver mobilization, hepatic vascular exclusion, and cardiopul-
monary bypass, can be determined by the level of thrombus.
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above the ostium of the renal vein and below the intrahep-
atic vena cava); level III or intrahepatic (i.e., extending into
the intrahepatic portion of the vena cava, but below the dia-
phragm); or level IV or atrial (i.e., extending into the right
atrium) (9).
Statistical analysis was performed using the statistical pack-
age SPSS for Windows (Version 12.0, SPSS Inc., Chicago, IL,
USA). Statistical significance was defined when a P value of
<0.05 was obtained. Overall survival rate was calculated using
the Kaplan-Meier method. 
Surgical procedure
Under general anesthesia, a central venous line and radial
artery catheter were placed to allow fluid administration and
blood pressure monitoring. Intraoperative continuous TEE
surveillance was used to detect tumor or gas emboli and to
confirm complete thrombus removal. 
Laparotomy was usually performed using an inverted T
incision or a chevron incision, both of which can be extended
to the thorax when cardiopulmonary bypass (CPB) is requir-
ed. The colon was retracted medially and the parietal peri-
toneum was incised over the kidney near the colon. In pati-
ents who did not undergo preoperative renal artery emboliza-
tion, the renal artery was ligated first. The colon was reflect-
ed medially to expose the IVC and aorta. The IVC was freed
from the lumbar veins, both renal veins were exposed, and
slings were passed around these structures, taking care not
to dislodge the thrombus. Following administration of hep-
arin, clamps were applied successively to the distal IVC, the
renal vein contralateral to the tumor, and the upper IVC prox-
imal to the thrombus. A lateral venotomy was performed
from the ostium of the tumoral renal vein to the IVC beyond
the proximal limit of the thrombus and the thrombus was
completely removed under direct vision (Fig. 1A, B). We
avoided blind digital extraction, milking, or Fogarty throm-
bectomy of IVC thrombus. The ostium of renal vein was sent
for frozen biopsy. Primary repair of the cavotomy was done
if the margin was free of the tumor, and when gross invasion
into the IVC wall was present cavectomy with prosthetic graft
interposition or patch angioplasty was performed (Fig. 1C).
After closure of the IVC, radical nephrectomy was performed.
Following surgery, patients were transferred to the intensive
care unit. Anticoagulation therapy, using low molecular-weight
heparin followed by antiplatelet agent(s), was administered
for 6 months after the procedure.
Surgical strategy based on the limit of thrombus extension
Operative maneuvers based on the limit of thrombus exten-
sion are summarized at Table 1.
Level I (renal) or II (infrahepatic) thrombus 
Liver mobilization was individualized depending on throm-
bus extent. If preoperative imaging showed sufficient space
to apply a proximal venous clamp, exposure of the IVC was
limited to the infrahepatic portion. Venous clamps were suc-
cessively positioned on the infrarenal IVC, the renal vein con-
tralateral to the tumor, and the IVC between the origin of
the hepatic veins and the limit of thrombus extension. 
Level III (intrahepatic) thrombus 
The liver was mobilized completely by the piggyback tech-
nique, dividing the falciform, triangular, and coronary liga-
ments, and the IVC was completely dissected from the renal
vein level to the hepatic veins. After complete hepatic mobi-
lization and IVC cross-clamping, hepatic vascular exclusion
was performed to prevent bleeding from the hepatic vein and
hepatic congestion. The suprahepatic IVC, the infrarenal IVC,
the contralateral renal vein, and the hepatic vein were occlud-
ed in sequence. Hepatic venous thrombi were removed with
a Fogarty catheter. 
Level IV (intraatrial) thrombus 
Laparotomy was associated with sternotomy for CPB. CPB
was started after cannulation of the aorta, superior vena cava,
and right femoral vein or infrarenal IVC. Deep hypothermia
was usually not used. After making a long venotomy below
the diaphragm, a right atriotomy for tumor mobilization and
Fig. 1. Operative pictures. After full exposure of the involved seg-
ment of the inferior vena cava (IVC), upper margin of thrombus
(A) and presence of remaining thrombus attached to the venous
wall is identified under direct vision (B). Since invasion into the vein
often starts from renal vein level, the venotomy site might be suc-
cessfully repaired without narrowing in case of resection of IVC
wall when incision was extended from renal vein ostium (C).
A B C
Liver 
mobilization
Hepatic vascular
exclusion
Cardiopulmo-
nary bypass
Level I, II ± --
Level III + + -
Level IV + + +
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extraction was performed. Complete removal of the throm-
bus was confirmed by inspecting and palpating the right atri-
um and the wall of IVC. 
RESULTS
The 35 patients consisted of 28 men and 7 women, of mean
age 56 yr (range, 32-77 yr). Eleven patients had tumors in
the right kidney and 24 in the left kidney. Median follow up
period was 28 months (range, 2-80 months). Preoperative
renal artery embolization was performed in 10 patients.
Based on histological findings, the tumors were classified
as pT3b in 22 patients (62.9%), pT3c in 6 (17.1%), and pT4
in 7 (20.0%) (Table 2). Pathological examination revealed
28 clear cell carcinomas (80.0%), 5 papillary cell carcinomas
(14.3%), 1 sarcomatoid carcinoma (2.9%), and 1 chromo-
phobe carcinoma (2.9%). Four patients (11.4%) had lymph
node metastases and 8 (22.9%) had distant metastases at the
time of diagnosis. 
The limit of tumor extension was level I in 10 patients
(28.6%), level II in 17 (48.6%), level III in 4 (11.4%), and
level IV in 4 (11.4%) (Table 2). Four patients had concomi-
tant iliac vein thrombosis. 
Right liver mobilization with hepatic vascular exclusion
was performed in 12 patients, 4 of 17 with level II thrombi,
4 of 4 with level III and 4 of 4 with level IV. CPB was used in
7 patients, including 2 with level III thrombi, 4 with intraa-
trial thrombi and 1 with intraoperative pulmonary embolism.
After thrombectomy, primary closure was possible in 32
patients (91.4%) without significant diameter loss, because
of dilatation of the IVC. Because of involvement of the IVC
wall, 2 patients required patch closure and 1 required graft
interposition (Table 2). Except three patients with recurrent
tumor of the IVC, all patients showed good patency of the
IVC (Fig. 2). 
There was no operative mortality or hepatic insufficiency.
However, simultaneous pulmonary embolectomy was per-
formed in 2 patients, both with infrahepatic thrombi, be-
cause of operative pulmonary embolism during dissection
and manipulation of the kidney and IVC. Patients with level
III and IV thrombosis required larger amount of mean blood
transfusion compared to patients with level I and II (14.8 vs.
5.9 packs, P<0.05). Operation time was significantly longer
in patients with level III and IV thrombosis than level I and
II (594.0 vs. 325.7 min, P<0.05). Likewise, postoperative
intensive care unit stay was longer (3.8 vs. 1.7 days, P<0.05).
The overall 5-yr survival rate was 50.6% and median sur-
vival was 54 months (Fig. 3A). Seventeen patients presented
with tumor recurrence, most commonly in the lungs (58.8
%). There were 11 (31.4%) late deaths during the follow-
up period. The 2-yr survival rate of patients with renal, infra-
hepatic, intrahepatic, and atrial tumor extension was 90.0%,
79.5%, 66.7%, and 50.0%, respectively (Fig. 3B). The 2-yr
survival rate of stage 3 and stage 4 was 82.5% and 64.3%
(Fig. 3C). Extent of tumor thrombus was not significantly
associated with survival, nor was stage, lymph node involve-
Fig. 2. Computed tomography of the patients with level IV thrombosis. Thrombus is extended to the suprahepatic IVC (A) and right atrium
(B). Coronal reconstruction view demonstrates IVC thrombus extended from left renal vein to the right atrium (C).
A B C
Number (%)
Level
I 10 (28.6)
II 17 (48.6)
III 4 (11.4)
IV 4 (11.4)
Stage
T3b 22 (62.9)
T3c 6 (17.1)
T4 7 (20.0)
Operation
Primary closure 32 (91.4)
Patch angioplasty 2 (5.7)
Graft interposition 1 (2.9)
Table 2. Number of patients according to level of tumor throm-
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ment, visceral involvement, or invasion of the IVC wall (P>
0.05 for each association).
Perioperative IVC filters were used in 8 patients, including
preoperative IVC filters in 3, intraoperative in 3, and post-
operative in 2. Four IVC filters were inserted for preventing
pulmonary embolism, 2 after pulmonary embolectomy, and
2 with pulmonary embolisms during follow-up. Intraopera-
tive IVC filter placement was performed through femoral
vein or internal jugular vein after IVC repair. One IVC fil-
ter which was inserted prophylactically, was retrieved dur-
ing surgery because it hindered proximal venous clamp. No
postoperative IVC occlusion was related to IVC filter use dur-
ing follow-up period. 
DISCUSSION
Treatment strategies of RCC has continued to evolve from
understanding of molecular and genetic characteristics of this
disease (15). However, patients with RCC and IVC throm-
bosis have major concern on immediate postoperative compli-
cation mainly from massive pulmonary embolism and bleed-
ing during surgery before getting benefit on outcome with
adjuvant therapies (1, 6, 7, 9). To proceed safe and success-
ful operation regarding IVC thrombectomy, first of all, inten-
sive intraoperative hemodynamic monitoring was required.
We found that patients with intraoperative pulmonary embo-
lisms showed sudden decreases in O2 saturation and blood
pressure, suggesting a need for continuous surveillance with
intraoperative bidimensional TEE. TEE is useful in the pre-
operative evaluation of thrombus extent, in detecting tumor
or gas emboli, and in intraoperative confirmation of complete
thrombus removal (6, 16, 17). In our experience, intraoper-
ative pulmonary embolism developed during dissection and
manipulation of the IVC and kidney, and we recommend
using TEE routinely at every stage of the procedure. 
Pulmonary embolisms can be prevented by sufficient expo-
sure of the IVC for proximal control and direct inspection of
involved IVC wall. Complete thrombus extraction without
tumor fragmentation can be achieved through liver mobiliza-
tion using liver transplantation techniques (18-22). Piggy-
back liver mobilization can ensure direct visualization of the
entire length of the IVC, thus permitting a cavotomy to be
extended when necessary. Reported complications of liver
mobilization include duodenal injury, liver laceration, and
pulmonary embolism, suggesting that liver mobilization be
limited to level III and IV tumor extensions and selected pati-
ents with level II extensions (13, 18, 21). These surgical strate-
gies also related with the long term outcome. Blind removal
of a thrombus can cause postoperative embolisms and early
disease recurrence because of tumor fragmentation and the
intraluminal persistence of part of a thrombus (21). Patients
with incomplete resection have a significantly worse prog-
nosis, and their five-year survival rates following surgery have
been reported to range from 0% to 17.5% (2, 7, 9). Our over-
all survival rate of 50.8% at 5-yr was similar to other reports
of tumor resection through long cavotomy under full expo-
sure of the involved IVC (3, 6). 
We found that lateral venotomy, starting from the ostium
of the affected renal vein, was convenient to effect repairs. In
case of tumor invasion of the caval wall, medial venotomy car-
ries a higher risk of narrowing after caval wall excision and
renal vein repair, and often requires caval wall reconstruction.
Other reported strategies that may prevent pulmonary
embolism include suprarenal IVC control using suprarenal
IVC clips, sternotomy with direct clamping, IVC interrup-
tion by suture/staple ligation, and placement of a suprarenal
IVC filter (23-27). Good technical success has been seen after
various types of filters were used, with venography at the time
of filter placement providing a preoperative assessment of the
extent of the tumor thrombus (26). Sosa et al. (28) reported
that preoperatively placed Mobin-Uddin vena caval umbrel-
las trapped tumor thrombi and/or clots in 5 of 7 patients.
Intraoperative deployment of a filter may protect the propa-
gation of bland thrombi in patients with distal thrombi as
well as tumor thrombi (27). In contrast, the overall rate of
vena caval thrombosis or occlusion and renal dysfunction asso-
ciated with infrarenal filter placement was 3-5%, suggesting
Fig. 3. Cumulative survival rate of RCC with IVC thrombosis patients. Overall survival rate (A) and stratified data according to extent of tumor
thrombus (B, P>0.05) and stage (C, P>0.05) are depicted. 
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that filter placement may increase significant overall morbidi-
ty in the setting of recent nephrectomy (24). Moreover, incor-
poration of the tumor in the filter may increase the difficul-
ty of complete resection (27). In our experience, use of pre-
operative IVC filters granted little room for applying venous
clamps and we had to remove one during operation. Because
direct inspection of involved IVC wall alone might decrease
chance of pulmonary embolism, we do not recommend the
prophylactic use of IVC filters. If IVC filter is required, care-
ful selection of the IVC filter location is crucial, based on the
extent of dissection.
Cardiopulmonary bypass or Pringle’s maneuver may min-
imize bleeding from the operative field, thus achieving hemo-
dynamic stability (13, 19, 29). CPB with or without hypo-
thermia and circulatory arrest may achieve stable hemody-
namic status during clamping of the IVC, thus providing a
bloodless operative field for tumor resection and venous recon-
struction in patients with level III or IV thrombi. However,
half of IVC thrombi are infrahepatic and only 10% are located
in the right atrium (11). Generally, CPB is the main cause
of a complex systemic inflammatory response, which signif-
icantly contributes to several adverse postoperative outcomes,
including renal, pulmonary, and neurological complications,
bleeding, and even multiple organ dysfunctions (5, 30). Post-
operative bleeding and coagulation disturbances were the
most frequently reported complications in patients who under-
went IVC thrombectomy with nephrectomy. Our findings
suggest that CPB is not always necessary to achieve nephrec-
tomy with thrombectomy of the IVC in patients without
intraatrial thrombi. We usually use CPB without hypother-
mia or circulatory arrest. Furthermore, when infrarenal IVC
is confirmed free from thrombus, we cannulate the infrarenal
IVC instead of the femoral vein. This does not require fur-
ther dissection of the femoral vein and may facilitate IVC
manipulation, reducing bleeding from the IVC and assur-
ing venous drainage of the lower extremities. Oblique appli-
cation of a vascular clamp across the infrarenal IVC and con-
tralateral renal vein can also assure renal venous drainage. 
Another reported surgical technique that may achieve
hemodynamic stability is aortic cross-clamping during IVC
thrombectomy. Partial or total cross-clamping of the infra-
renal or supraceliac segment of the abdominal aorta can main-
tain systemic blood pressure above 100 mmHg by maintain-
ing venous return (13). However, in our experience, even
patients without venous occlusion tolerated this procedure
without significant hemodynamic instability, and transient
hypotension could be managed by fluid and blood adminis-
tration. 
The role of anticoagulation after operation for preventing
recurrent IVC thrombosis is not well described in many arti-
cles. The brief use of low molecular weight heparin or dex-
tran was reported during the immediate postoperative peri-
od to prevent deep vein thrombosis (19, 26).
In conclusion, our findings suggest that safe IVC thrombec-
tomy can be accomplished by vigilance on hemodynamic
status and by complete thrombus removal without fragmen-
tation through long venotomy on fully exposed involved
IVC. Individual surgical planning is necessary, including liver
mobilization, hepatic vascular exclusion, and possible CPB,
depending on the level of thrombus.
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